September 27, 2018
Closeup of a CT scan of 67 year old woman brain.
The historic move marks the first time the DEA has formally recognized a cannabidiol-based formulation as legal and safe. The US Drug Enforcement Administration today announced the reclassification of Epidiolex, a plant-derived cannabidiol (CBD) prescription medicine approved by the FDA in June for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, two rare and severe...
Read More